Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease
Conditions: Diabetic Nephropathies; Diabetic Kidney Disease Interventions: Drug: Astragalus Powder; Other: Routine medical care (active comparator) Sponsors: The University of Hong Kong; School of Chinese Medicine, The University of Hong Kong Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Astragalus | China Health | Diabetes | Endocrinology | Hong Kong Health | Urology & Nephrology